Sales declined 5% in Q2 2026 with organic growth at -1%, while gross margin improved to 30.1%. Profitability was impacted by restructuring costs and bad debt, but free cash flow remained positive. The company extended its restructuring program to address ongoing market weakness.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.